BioPharmSignal logoBioPharmSignal

Biotech News

Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results

Privia Health (PRVA)Privia HealthEarnings

All 2025 Operating and Financial Metrics At or Above High End of Guidance Ranges Full-year 2025 Net Income +59.3% from 2024 Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024 Full-year 2025 Net Cash Provided by Operating Activities of $163.4 Million, +49.5% from 2024; Year-end 2025

Related news

PRVAPrivia Health2026-05-07 10:00 EST

Privia Health Reports First Quarter 2026 Financial Results

PRVAPrivia Health2025-11-06 11:00 EST

Privia Health Reports Third Quarter 2025 Financial Results

View all latest news

Privia Health

Physician Enablement Platform Privia Health supports independent physicians with technology and services that allow practices to remain physician-led while operating within scaled medical groups. Provider Networks The company builds primary-care-centered provider networks, risk-bearing entities and local medical groups with shared...

Recent company news

PRVAPrivia Health2026-08-18 13:00 EST

Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors

PRVAPrivia Health2026-08-06 10:00 EST

Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results

PRVAPrivia Health2026-07-07 13:00 EST

Privia Health to Report Second Quarter 2026 Results on Thursday, August 6

PRVAPrivia Health2026-05-27 13:00 EST

Privia Health Enters New Jersey

PRVAPrivia Health2026-05-07 10:00 EST

Privia Health Reports First Quarter 2026 Financial Results

Stock data

Close
21.50 USD
Market cap
2.62B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States